Why the study?
Non-pharmacological therapies play an essential role complementing pharmacological treatments in heart failure management, warranting an updated perspective on interventions and management in special populations.
Non-pharmacological interventions, including lifestyle changes and device therapies, are essential complementary strategies to optimize care and outcomes in heart failure, especially in special populations.
Answers are grounded in this paper and cite their sources.
Non-pharmacological therapies may complement HF care in vulnerable groups; leaves open need for prospective trials to confirm outcomes.
Non-pharmacological therapies play an essential role in the management of heart failure, complementing pharmacological treatments to mitigate disease progression and improve patient outcomes. This review provides an updated perspective on non-pharmacological interventions with a focus on lifestyle modifications, device therapies, and the management of heart failure in special populations, such as the elderly, women, and patients with comorbid conditions like renal dysfunction and diabetes. Key lifestyle interventions, including sodium and fluid restriction, dietary changes, and physical activity, are explored for their impact on symptom reduction, hospital readmissions, and quality of life. Device therapies like cardiac resynchronization therapy (CRT) and implantable cardioverter defibrillators (ICD) are also evaluated for their effectiveness in reducing mortality in patients with advanced HF. Special attention is given to vulnerable populations, emphasizing the need for individualized approaches tailored to specific pathophysiological mechanisms and socioeconomic factors. By integrating these strategies, healthcare providers can optimize care and enhance patient adherence, reducing the overall burden of heart failure.
No takes yet. Share an insight, caveat, or question.
Dugal et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: